tailieunhanh - Pharmaceutical Substances Syntheses, Patents, Applications - Part 207

Pharmaceutical Substances Syntheses, Patents, Applications - Part 207. Reference containing a collection of 2267 active pharmaceutical ingredients, including those launched recently. Listed alphabetically according to their INNs and established a link between INNs, structure, synthesis and production processes, patent and literature situation, medical use, and trade names. For pharmacists and researchers. | Tizanidine T 2061 Tizanidine ATC MO3BXO2 Use skeletal muscle relaxant RN 51322-75-9 MF C9H8C1N5S MW LD50 235 mg kg M . 600 mg kg R . CN 5-chloro- V- 4 5-dihydro-lH-imidazol-2-yl -2 l 3-benzothiadiazol-4-amine hydrochloride RN 64461-82-1 MF C9H8C1N5S HC1 MW SOCIj DMF A 1. HNO3 H2S04 2. Fe CHjCOOH k Cl2CS ----------- thiophosgene 4-chloro-t 2- 5-chloro-2 1 3- diaminobenzene benzothiadtazole 5-chloro-4- ethylene- isothiacyonato- diamine Pb OCOCH3 2 KOH ------------ lead ll acetate 2 1 3-benzothiadiazole Reference s DE 2 322 880 Sandoz appl. prior. . US 3 843 668 Sandoz appl. CH-prior. . CH 579 565 Sandoz appl. . synthesis ö 4-amino-5-chloro-2 l 3-benzothiadiazole Pesin . . Khaletskil . Zh. Obshch. Khim. ZOKHA4 27 2599 1957 . . CHABA8 52 7292. Smith . Chen J. Org. Chem. JOCEAH 27 676 1962 . Formulation s tabi. 2 mg 4 mg 6 mg as hydrochloride Trade Name s D Sirdalud Sanofi Winthrop GB Zanaflex Athena 1985 J Teonelin Sandoz USA Zanaflex Athena Tobramycin atc-. JOiGBoi soiaai2 Use antibiotic RN 32986-56-4 MF C18H37N5O9 MW EINECS 251-322-5 LD5 mg kg M . 11500 mg kg M . 104 mg kg R . 7500 mg kg R . CN O-3-amino-3-deoxy-a-D-glucopyranosyl- l 6 -6 - 2 6-diamino-2 3 6-trideoxy-a-D-ribtf-hexopyranosyl- 1 4 -2-deoxy-D-streptamine 2062 T Tobramycin sulfate RN 49842-07-1 MF Cl8H37N5O9 xH2SO4 MW unspecified EINECS 256-499-2 LD5o 77 mg kg M . 10500 mg kg M . 126 mg kg R . from fermentation solutions of Streptomyces tenebrarius ATCC 17920 or ATCC 17921 bekanomycin q. v. ATP E. coli R11 IF0 13560 -------------------------------k adenosine triphosphate 1. H3C 3SiCI H5C6 3P. h3C- S CH3 3 N Si CH3 3 2. Raney-Ni H20 I --------------------------------------------------- 1. trimethylchlorosilone triph enylphasphine. N 0-bis trimethylsilyl ocetamide nh2 I Reference s a US 3 691 279 Lilly prior. . DE 1 792 819 Lilly . b DOS 2

• Sinh học
• 2267 hoạt chất dược phẩm
• Sách nghiên cứu dược
• hoạt chất dược phẩm
• tổng hợp quá trình sản xuất
• sáng chế thuốc